We Should Talk: Interoperability and the NHS

IMS MAXIMSA new report calls on the Department of Health to strengthen its efforts to encourage data sharing in the NHS. Paul Cooper, IMS MAXIMS Head of Research, co-authored 'We Should Talk: Interoperability and the NHS', on behalf of Intellect, the trade association representing the UK's IT, electronics and telecoms industries. The document scrutinises the effectiveness of the Interoperability Toolkit (ITK) - a set of standards and frameworks designed to help the NHS across England to connect IT systems with one another.

The report praises much about the ITK, especially its recognition that the greatest benefits can be achieved at a local level, and that some interoperability is better than none. It goes on to recommend that far more needs to be done to engage suppliers and says a major drive is needed to persuade many people within the NHS that interoperability is vital to the success of their organisations.

Paul Cooper said: "There is a huge problem in the NHS because many of the IT systems cannot talk to each other. This means that staff often can't get access to the information they need. Clinicians can only do the best for patients if they have all the relevant information about their conditions, and hospitals can only deliver efficient services if they have the data to identify bottlenecks in their systems or areas of waste.

"An efficient healthcare system, which delivers the best for patients and makes effective use of resources, can only exist if data can be shared within and between organisations. The good news is that these problems can be overcome and that everyone within the healthcare IT sector accepts that interoperability is the way forward. But too many people in the NHS still see interoperability as a technical matter rather than something which allows them to do their jobs better.

"The ITK initiative must do more to persuade everyone from medical and nursing directors, to FDs and CEOs that this is a mission critical issue. Suppliers provide what trusts ask for, and interoperability will only get to the top of the agenda if it's central to what the customer demands."

The report also calls for closer and more productive links to be established between the DH, the NHS, Intellect and its members. For the ITK to be a success, it argues, there must be productive and collaborative engagement with suppliers.

We Should Talk: Interoperability and the NHS, was written by Paul Cooper of IMS MAXIMS and Martin Whittaker of the Touchstone Consultancy, both of whom are members of the Intellect Healthcare Council. It was published in September 2011 and can be downloaded at http://www.intellectuk.org/component/docman/doc_download/5564-we-should-talk-interoperability-and-the-nhs-sept-2011.

About IMS MAXIMS
IMS MAXIMS is the company behind the widely-used MAXIMS clinical PAS. It is a specialist in developing clinical and administrative software solutions and currently supports more than 100 organisations and 10,000 users of IMS MAXIMS products.

To find out more about IMS MAXIMS and its products visit www.imsmaxims.com.

About the MAXIMS clinical PAS
MAXIMS gives clinicians the applications they need to provide the best possible patient care, and allows provider organisations to manage their patient administration with ease and efficiency. Rival products often tend to be administrative systems with clinical software added on. MAXIMS is equally focused on the needs of clinicians and provider organisations - which we believe is the way to guarantee the best patient outcomes with optimum efficiency.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...